| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1f0689790ad4144b2c6143e716e58aa2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7422ee4e5e121fd6fbc63448253ec5ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_823836c1c402a20ce72579f32a17901a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_687e61c9f42eac8f4850c6a0f855d48b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b2cc6e3d88e27a0ec7a61dff186e5279
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12bff734c55daf2903aa83c8744a3da9 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-473
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4741 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D455-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-473 |
| filingDate |
2001-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d13e40f2289a5018c56a53cad5d6eb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_267cd734c9c3a9dedd1e836af641f988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_315d326cc9f08162bbc47b8c1fc205d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8942b402ac32ba4cf4fc0ed951d64d69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9e92ec3e27ea932b5b0dc0f3157e342 |
| publicationDate |
2001-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0195908-A1 |
| titleOfInvention |
Protoberberine derivatives which inhibit activity of the mitogen-activated protein kinase |
| abstract |
The present invention relates to protoberberine derivatives which inhibit the activity of mitogen-activated protein kinase. More specifically, the present invention is directed to protoberberine derivatives which inhibit the activity of Wis1 and Spc1 kinase in intracellular signal transduction cascade wherein mitogen-activated protein kinase (MAPK) is involved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2405755-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2405755-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011009714-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8188109-B2 |
| priorityDate |
2000-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |